Search results
Found 9279 matches for
Oxford/Celgene Fellowship to analyse neutrophil chromatin organisation in rheumatic patients
Awards Funding
8 November 2017
We would like to congratulate Tariq Khoyratty, who has been appointed as a Celgene Fellow to study the link between neutrophil chromatin organisation in rheumatic patients and their ability to form pathogenic extracellular traps.
Oxford-Elysium Fellowship in Autophagy
Funding
30 October 2017
Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.
The Arthritis Research UK Centre for Osteoarthritis Pathogenesis receives 5-year award
Funding oacentre
12 October 2017
Arthritis Research UK has approved a 5-year renewal of the OA Centre.
Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation
Publication
20 September 2017
Recent research from the Simon Group has discovered an unexpected novel role that autophagy plays during the generation of neutrophils.
ARUK award two Clinical Fellowships looking into Osteoarthritis of the Hand.
Department Funding oacentre
14 September 2017
Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.
Professor Michael Dustin elected as EMBO member
Awards Department General
9 August 2017
Many congratulations to Professor Michael Dustin on his election as a member of the European Molecular Biology Organisation (EMBO).
Green Impact Award for the Kennedy Team
1 August 2017
Staff at the Kennedy are celebrating receipt of a Bronze Award from Green Impact.
Professor Powrie to become new Wellcome Governor
Awards
19 July 2017
Fiona Powrie, Director of the Kennedy Institute of Rheumatology is joining Wellcome as a new Governor in Jan 2018. Fiona says she’s thrilled to join Wellcome: "It’s an organisation I’ve admired since I started my research career. Through funding great scientific ideas, Wellcome is committed to promoting health around the world. It will be an honour to help deliver this goal."
Dopamine rewards immune cells through immunological synapse
16 July 2017
Researchers at the Kennedy Institute of Rheumatology at the University of Oxford mapped dopamine and the consequences of its release to the immunological synapse.
Kennedy Institute investigator receives MRC Career Development Award
Awards
3 July 2017
Dr Anjali Kusumbe has been awarded an MRC Career Development Award to support her research examining how blood vessels support bone growth and repair.
Expanding clinical research at the Kennedy Institute
Department Funding
31 May 2017
Christopher Buckley joins the Kennedy Institute as a new Director of Clinical Research from May 2017.
The art and science of arthritis
General oacentre
7 April 2017
Artist in residence at the Kennedy Institute unveils her ‘Healing Hands’ exhibition examining the art and science of arthritis.
New potential treatment target for patients with inflammatory bowel disease
Publication
3 April 2017
A new study published today in Nature Medicine could change the lives of millions of people living with inflammatory bowel diseases (IBD) who don’t respond to the current standard of care.
Women who inspire us
Department
9 March 2017
To celebrate International Women’s Day we asked NDORMS staff and students to tell us about the women who inspire them. These are their stories.
Time to be positive about negative data?
Publication oacentre
6 March 2017
Professor Tonia Vincent writes in Osteoarthritis and Cartilage about the importance of making negative data more accessible in osteoarthritis research.
Dr Luke Jostins joins the Kennedy Institute
General
13 January 2017
Dr Luke Jostins joins the Kennedy Institute to lead a new research group that will develop statistical methods to decode the genetics of complex immune diseases.
Kennedy Institute publishes 2016 Report
15 December 2016
M40 Alliance forms to accelerate arthritis therapy
General
7 December 2016
A new partnership has been formed between the Universities of Oxford and Birmingham to speed up the development of novel treatments for arthritis, supported by a £7 million investment from the Kennedy Trust for Rheumatology Research.